Acadia Pharmaceuticals, INC.
Biopharmaceutical company.
Based in CA
🤖
AI Overview
With $1.7M in lobbying spend across 22 quarterly filings, Acadia Pharmaceuticals, INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2020 to 2025.
$1.7M
Total Spend
6
Years Active
1
Firms Hired
7
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $80K |
| 2021 | $320K |
| 2022 | $320K |
| 2023 | $320K |
| 2024 | $320K |
| 2025 | $320K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Taxation
- •Issues affecting the pharmaceutical industry.
- •Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to Medicare reform.
- •Issues related to the U.S. Food and Drug Administration (FDA); Issues related to drug pricing; Issues related to nursing home quality measurement.
- •Issues related to drug pricing in H.R. 5376 - the Build Back Better Act; Issues related to nursing home quality measurement.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.